EssilorLuxottica : EssilorLuxottica and GrandVision enter into an agreement with ORIG BENE, a member of MPG Austria, for the sale of stores in the Netherlands and Belgium

3 years ago

EssilorLuxottica and GrandVision enter into an agreementwith ORIG BENE, a member of MPG Austria, for the saleof stores in the…

Disclosure of received notification of The Capital Group Companies

3 years ago

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 23 December 2021 – 7:00 PM CET Disclosure of received notification of The Capital Group…

FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product

3 years ago

VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible Cigarette to Receive FDA MRTP…

Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site

3 years ago

Saint Herblain (France), December 23, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

CENTR Brands Corp. Corporate Update

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - December 24, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company") is…

CVR Medical Corp. Announces Closing of Capital Raise

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - December 23, 2021) - CVR Medical Corp. (TSXV: CVM) (OTC Pink: CRRVF) ("CVR Medical" or…

Empatho Holdings Inc. Receives Final Approval for Listing and Announces Start of Trading on the Canadian Securities Exchange

3 years ago

Toronto, Ontario--(Newsfile Corp. - December 23, 2021) - Empatho Holdings Inc. (formerly, Shane Resources Ltd.) (the "Company") is pleased to…

Cannabis Suisse Corp. Reports Year Results for 2021

3 years ago

DIETIKON, SWITZERLAND / ACCESSWIRE / December 23, 2021 / Cannabis Suisse Corp. (OTC PINK:CSUI), registered in the state of Nevada,…

Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics

3 years ago

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this…

Cassava Sciences Launches Clinical Website to Support Phase 3 Studies of Oral Simufilam in Alzheimer’s Disease

3 years ago

New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants.Rethink-ALZ.com connects patients with nearest participating clinical…